XML 46 R36.htm IDEA: XBRL DOCUMENT
v3.26.1

Earnings per Share (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2026
Earnings Per Share [Abstract] |
Summary of Earnings Per Share, Basic and Diluted | The following table sets forth the reconciliation of the numerator and denominator used to calculate basic and diluted earnings per Class A ordinary share (in thousands, except per share amounts):
|  |  | For the Three Months Ended March 31,
|  |  |  |  | 2026 |  | 2025
Numerator |  |  |  |  |  |  |
Consolidated net income(1) |  |  |  |  | $ | 468,256 |  |  | $ | 434,433 |
Less: Net income attributable to the Continuing Investors Partnerships |  |  |  |  | 78,049 |  |  | 76,758 |
Less: Net income attributable to the Legacy Investors Partnerships |  |  |  |  | 63,213 |  |  | 76,850 |
Less: Net income attributable to the Founder’s Equity(2) |  |  |  |  | 15,894 |  |  | 41,476 |
Less: Net income attributable to the RP Holdings Class E Interests Holders |  |  |  |  | 16,410 |  |  | — |
Net income attributable to Royalty Pharma plc - basic |  |  |  |  | 294,690 |  |  | 239,349 |
Add: Reallocation of net income attributable to the Continuing Investors Partnerships from the assumed exchanges of Class B ordinary shares |  |  |  |  | 78,049 |  |  | 76,758 |
Add: Reallocation of net income attributable to the Holders of RP Holdings Class E Interests from the assumed exchanges of eligible Class B ordinary shares |  |  |  |  | 2,484 |  |  | — |
Net income attributable to Royalty Pharma plc - diluted |  |  |  |  | $ | 375,223 |  |  | $ | 316,107 |
Denominator |  |  |  |  |  |  |
Weighted average Class A ordinary shares outstanding - basic |  |  |  |  | 436,790 |  |  | 435,480 |
Add: Dilutive effects as shown separately below |  |  |  |  |  |  |
Assumed exchanges of Class B ordinary shares by the Continuing Investors Partnerships |  |  |  |  | 115,840 |  |  | 141,974 |
Unvested RSUs |  |  |  |  | 163 |  |  | 48 |
Shares contingently issuable for the Equity Performance Awards |  |  |  |  | 358 |  |  | 600 |
Assumed exchanges of eligible Class B ordinary shares by the Holders of RP Holdings Class E Interests |  |  |  |  | 3,686 |  |  | — |
Weighted average Class A ordinary shares outstanding - diluted |  |  |  |  | 556,837 |  |  | 578,102 |
Earnings per Class A ordinary share - basic |  |  |  |  | $ | 0.67 |  |  | $ | 0.55 |
Earnings per Class A ordinary share - diluted |  |  |  |  | $ | 0.67 |  |  | $ | 0.55 |
(1)Consolidated net income for 2025 has been recast as a result of the adoption of ASU 2025-07. See Note 2–Summary of Significant Accounting Policies for further details. (2)Amounts for 2025 includes Mr. Legorreta’s retained EPAs and employees’ participation in the EPAs, which were considered part of Founder’s Equity prior to the closing of the Internalization.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration